Catalyst Wire Dossier Catalyst Wire Dossier

DEFLAZACORT ORAL SUSPENSION

deflazacort · Cranbury Pharmaceuticals, LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for DEFLAZACORT ORAL SUSPENSION, covering 2024-04-25 to 2026-01-27. Get the full timeline:

Most recent: FDA Approved: DEFLAZACORT ORAL SUSPENSION — Original Application (Sun Pharmaceutical Industries, Inc.)

See pricing